Skip to main content

Crescent Capital BDC, Inc. Reports First Quarter 2026 Earnings Results; Declares a Second Quarter Base Dividend of $0.34 Per Share and Series of Special Dividends

LOS ANGELES, May 13, 2026 (GLOBE NEWSWIRE) — Crescent Capital BDC, Inc. (“Crescent BDC” or the “Company”) (NASDAQ: CCAP) today reported net investment income of $0.42 per share and net income of ($0.42) per share for the quarter ended March 31, 2026. Net asset value (NAV) per share was $18.27 at March 31, 2026. Subsequent to quarter end, the Company reduced its fee structure, lowering its base management fee from 1.25% to 1.00% and its incentive fee from 17.5% to 15.0%, effective April 1, 2026, further aligning interests with shareholders and supporting the durability of its earnings profile. Dividend DeclarationsThe Company announced that its Board of Directors (the “Board”) declared a second quarter 2026 regular cash dividend of $0.34 per share to stockholders of record as of June 30, 2026, payable on July 15, 2026, and a series...

Continue reading

Venus Concept Announces Senior Management Changes

TORONTO, May 13, 2026 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced changes to its senior leadership team. Kirk Gunhus, Chief Revenue Officer, departed the Company as of May 8th, 2026, to pursue another professional opportunity. Mr. Gunhus joined Venus in 2023 and had a central role in shaping the Company’s global commercial strategy during a pivotal turnaround period. The Company expresses its appreciation for Mr. Gunhus’s contribution to Venus Concept. With his departure, Venus Concept has appointed Eric Letourneau to the position of Vice President, Sales, USA, with responsibility for Sales, Practice Development and Sales Training, in the United States. Internationally, Ross Portaro, EVP Commercial Strategy and Head of Venus Hair, assumes...

Continue reading

MariMed Reports First Quarter 2026 Earnings

NORWOOD, Mass., May 13, 2026 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the first quarter ended March 31, 2026. Financial Highlights1 The following table summarizes the Company’s consolidated financial highlights (in millions, except percentage amounts):  Three months ended March 31,  2026   2025  (unaudited)Revenue $ 39.5     $ 37.9  GAAP Gross margin   39 %     40 %Non-GAAP Gross margin   40 %     41 %GAAP Net loss $ (3.8 )   $ (5.5 )Non-GAAP Net loss $ (3.2 )   $ (3.9 )Non-GAAP Adjusted EBITDA $ 3.6     $ 2.5  Non-GAAP Adjusted EBITDA margin   9 %     7 %1 See the reconciliations of non-GAAP financial measures to the most directly...

Continue reading

Stantec reports first quarter 2026 results, achieving record backlog of $9.0 billion, and adjusted earnings per share growth of 14.7%

HighlightsNet revenue of $1.7 billion, an increase of 9.1% compared to Q1 2025 Adjusted EBITDA1 increase of 13.8% to $287.0 million and adjusted EBITDA margin1 of 16.9%, a 70 basis point increase over Q1 2025 Diluted EPS of $0.97 and adjusted EPS1 of $1.33, up 10.2% and 14.7%, respectively, compared to Q1 2025 Contract backlog increased to $9.0 billion, up 13.2% year-over-year Reaffirms mid-to-high single digit organic growth guidance for 2026.EDMONTON, Alberta and NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) — Stantec (TSX, NYSE:STN), a global leader in sustainable engineering, architecture and environmental consulting, released its first quarter 2026 results today. In the first quarter, net revenue increased to $1.7 billion, a 9.1% year-over-year increase, driven by 3.6% organic and 7.2% acquisition growth1. Stantec achieved...

Continue reading

Aptose Reports First Quarter 2026 Results 

SAN DIEGO and TORONTO, May 13, 2026 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly diagnosed acute myeloid leukemia (AML), today announced financial results for the first quarter ended March 31, 2026, and provided a corporate update.    “Our TUSCANY clinical trial of tuspetinib in combination with venetoclax (VEN) and azacitidine (AZA) for frontline treatment of newly diagnosed acute myeloid leukemia (AML) continues to deliver robust safety and response data, and we’re pleased that an update of our TUS+VEN+AZA triplet clinical data has been selected for an oral presentation at the upcoming EHA2026 Congress in June,” said William G. Rice, Ph.D.,...

Continue reading

Condor Announces 2026 First Quarter Results

CALGARY, Alberta, May 13, 2026 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX:CDR), a Canadian based, internationally focused energy transition company focused on Central Asia is pleased to announce the release of its unaudited interim condensed consolidated financial statements for the three months ended March 31, 2026 (the “Financial Statements”), together with the related management’s discussion and analysis. These documents will be made available under Condor’s profile on SEDAR+ at www.sedarplus.ca and on the Condor website at www.condorenergies.ca. Readers are invited to review the latest corporate presentation available on the Condor website. All financial amounts in this news release are presented in Canadian dollars, unless otherwise stated. HIGHLIGHTSProduction in Uzbekistan for the first quarter...

Continue reading

Epsilon Announces First Quarter 2026 Results

HOUSTON, May 13, 2026 (GLOBE NEWSWIRE) — Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported first quarter 2026 financial and operating results. Q1 2026 Highlights:Epsilon – Q1 2026                Q1 2026 Q4 2025 Q1 2025 QoQ% YoY%NRI Production             Gas MMcf 2,482 2,373 2,740 5% -9%Oil MBbl 136 94 46 45% 199%NGL MBbl 42 43 16 -2% 168%Total MMcfe 3,554 3,196 3,108 11% 14%Daily Total MMcfe/d 39.5 34.7 34.5    Daily Oil Bbl/d 1,515 1,021 506                 Revenues  $M          Gas    13,403 6,839 10,614 96% 26%Oil   9,462 5,299 3,270 79% 189%NGL   1,073 1,180 387 -9% 177%Midstream1    1,658 1,501 1,892 10% -12%Total    25,596 14,818 16,163 73% 58%             Realized Prices2            Gas  $/Mcf 5.40 2.88 3.87 87% 39%Oil  $/Bbl 69.39 56.44 71.76 23% -3%NGL $/Bbl 25.32 27.17 24.52 -7% 3%             Adj....

Continue reading

Kneat Announces Record Revenue for First Quarter 2026

LIMERICK, Ireland, May 13, 2026 (GLOBE NEWSWIRE) — kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, today announced financial results for the three months ended March 31, 2026. All dollar amounts are presented in Canadian dollars unless otherwise stated. Total revenue reaches $18.0 million in the first quarter, an increase of 22% year over year Annual Recurring Revenue (ARR)1 at March 31, 2026, reaches $76.4 million, an increase of 20% year over year Gross profit growth accelerates for the second quarter in a row, reaching 28% year over year“The first quarter of 2026 reflected consistent execution and continued validation of our strategy. As the life sciences industry continues its transition to fully digital validation, Kneat is well...

Continue reading

Bird Reports 2026 First Quarter Results; 9% Revenue Growth and Record Backlog

MISSISSAUGA, Ontario, May 13, 2026 (GLOBE NEWSWIRE) — “Bird delivered a strong start to 2026, with organic revenue growth, stable margins and solid cash flow that reflect the resilience of our diversified One Bird platform,” said Teri McKibbon, President and CEO of Bird Construction. “Record contracted backlog and a sizable pending backlog provide clear visibility into future activity and demonstrate continued demand across our key strategic sectors. Supported by a strong balance sheet and ample liquidity, we remain focused on safe execution and continued margin accretion as we advance toward achieving our 2027 Strategic Plan objectives.” FINANCIAL HIGHLIGHTSBird reported first quarter revenue growth of 9.2% compared to the first quarter of 2025. Strong organic revenue growth in the Buildings business was partially offset...

Continue reading

North American Construction Group Ltd. Announces Results for the First Quarter Ended March 31, 2026

Adjusted EBITDA of $99.5 million for the First Quarter of 2026 ACHESON, Alberta, May 13, 2026 (GLOBE NEWSWIRE) — North American Construction Group Ltd. (“NACG”) (TSX:NOA/NYSE:NOA) today announced results for the first quarter ended March 31, 2026. Unless otherwise indicated, figures are expressed in Canadian dollars, and comparisons are to the prior period ended March 31, 2025. First Quarter 2026 Financial Highlights Combined Revenue:$422.5 million, up 8% year-over-year and up 23% sequentially from Q4 2025 Reported revenue: $319.2 million, down 6% year-over-year and up 4% sequentially from Q4 2025Adjusted EBITDA:$99.5 million, flat year-over-year and up 28% sequentially from Q4 2025 Net income: $5.6 million, down 10% year-over-year and up from $0.1 million in Q4 2025Free Cash Flow:$3.7 million inflow, up $45.2...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.